The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Lantus

Profit at drugmaker Sanofi up 35 pct for 1st half but full-year core earnings expected to fall - Washington Post

Strong growth in the Paris-based company?s diabetes drug Lantus and a record year for flu vaccines sales helped drive earnings from January to June to ?3 billion ($3.64 billion). Revenue for the period was ?17.4 billion, up 8 percent from ...

Biocon Announces Positive Results from its Phase 1 Comparative PK-PD Study with Biosimilar Insulin Glargine - andhranews.net

This randomized, double-blind, euglycemic clamp study was conducted in T1DM patients to evaluate pharmacokinetic (PK) and pharmacodynamic (PD) equivalence of Biocon?s Insulin Glargine against the innovator product (Lantus). The trial met all its ...

Biocon's phase 1 comparative PK-PD study with biosimilar insulin glargine meets primary and secondary endpoints - pharmabiz.com

This randomized, double-blind, euglycemic clamp study was conducted in T1DM patients to evaluate pharmacokinetic (PK) and pharmacodynamic (PD) equivalence of Biocon?s Insulin Glargine against the innovator product (Lantus). The trial met all its primary ...

Sanofi Still Surprising And Surpassing - Seekingalpha.com

One of the strengths of Sanofi is also an area of concern for me. Diabetes care kicks in over 15% of total revenue, largely on the back of basal insulin analog Lantus. While Sanofi still has multiple years of patent coverage for Lantus, I do worry that ...

Elevated Blood Glucose Levels after Carpal Tunnel Hand Surgery - HealthCentral.com

It's now late July and my blood sugar levels are still in the 230s. I take Lantus twice a day. What can I do? I have a constant headache, jaw pain, teeth hurt; can this be making my level stay high? My reply: Something doesn?t quite fit together here.

New diabetes treatment added to Pharmacare - halifaxnewsnet.ca

Nova Scotians with diabetes will have access to another type of insulin under the provincial Pharmacare program. Effective Aug. 1, Lantus, a long-acting insulin, will be added as a benefit on Pharmacare for eligible patients who need an alternative to NPH ...

Generic Plavix & Avapro Hurt Sanofi - Yahoo Finance

The diabetes franchise (up 13.7% to ?1.4 billion) continued performing well with growth driven by Lantus (up 16.5% to ?1.2 billion). Apidra sales were flat at ?56 million in second quarter 2012. Global sales of Plavix, an anti-platelet ...

Sanofi posts slower Q2 drop, keeps 2012 outlook - Reuters

Sales in the quarter rose 6.2 percent to 8.87 billion euros, driven by emerging markets and double-digit growth in diabetes treatment Lantus, as well as the effect of the weaker euro. At constant exchange rates sales increased 0.4 percent.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/script>
 

/script>
 
Blogspot logo    Latest Posts from Marc Faber blog
 
Blogspot logo    Latest Posts from Henrique Simoes blog
 
  Latest Posts from Mad Money 
Cramer Remix: The key chart patterns all investors should keep in mind
Cramer unveils the scariest pattern in the chart book
Cramer shares the unusual signs that mean a stock is ready to explode
Cramer's guide to finding bulletproof stocks using charts
Cramer: How to use charts to detect a phony rally on Wall Street
 
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
 
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\rss_fetch.inc on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 436

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 437
 
Blogspot logo    Latest Posts from Random Roger
A Financial Advisor Has Got To Know His Limitations
A Lot of Market Stuff & the Maui Invitational!
Shiller Is Wrong
Very Odd And Unfamiliar Crimson Hue On My Screens
Don?t Get Done In By Unintended Overweight Exposure
 
  Home

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News
  Technology
  Blogs

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis

  Sitemap
  Gold
  Silver
  Platinum
  Palladium
  Rhodium

         

               
                 Copyright Leaderglobe.